Galderma

Galderma is a pure-play dermatology company founded in 1981, with more than 40 years dedicated to skin health. It develops science-based solutions across three business units: Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. The company reported net sales of USD 4.410 billion in 2024 and employs more than 7,000 people, operating in approximately 90 countries. Galderma listed on the SIX Swiss Exchange in 2024.

Technical work spans dermatology, aesthetic injectables, dermatological skincare, therapeutic dermatology and pharmaceutical research and development. The company also runs the Global Aesthetic Injector Network, a training and education programme for healthcare professionals in aesthetic injection techniques, and pursues an integrated dermatology strategy intended to drive innovation and partnership across its segments.

Galderma traces its origins to a joint venture between Nestlé and L'Oréal and has operated as an independent company since separating in 2019. Stated cultural signals include an emphasis on scientific rigour, partnership with healthcare professionals, investment in training and education, and recognition that individual skin needs vary. The company's products are sold globally, with its listing in Switzerland.